With bank failures and volatile markets this year, it is more important than ever for early-stage companies to demonstrate their distinct strengths as investors evaluate their priorities. Attend this presentation to hear data on venture trends compiled by HSBC Innovation. Investors and biotech executives will then offer their approaches for raising capital in this environment to ensure continued company growth.